10-46580964-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_031912.5(SYT15):āc.283G>Cā(p.Glu95Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000072 ( 0 hom., cov: 22)
Exomes š: 0.0000018 ( 1 hom. )
Failed GnomAD Quality Control
Consequence
SYT15
NM_031912.5 missense
NM_031912.5 missense
Scores
3
6
Clinical Significance
Conservation
PhyloP100: 1.57
Genes affected
SYT15 (HGNC:17167): (synaptotagmin 15) This gene encodes a member of the Synaptotagmin (Syt) family of membrane trafficking proteins. Members of this family contain a transmembrane region and a C-terminal-type tandem C2 domain. Unlike related family members, the encoded protein may be involved in membrane trafficking in non-neuronal tissues. Two trancript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.23323885).
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 1AN: 137962Hom.: 0 Cov.: 22 FAILED QC
GnomAD3 genomes
AF:
AC:
1
AN:
137962
Hom.:
Cov.:
22
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248868Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135056
GnomAD3 exomes
AF:
AC:
3
AN:
248868
Hom.:
AF XY:
AC XY:
2
AN XY:
135056
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000184 AC: 2AN: 1086274Hom.: 1 Cov.: 16 AF XY: 0.00000373 AC XY: 2AN XY: 536802
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
2
AN:
1086274
Hom.:
Cov.:
16
AF XY:
AC XY:
2
AN XY:
536802
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000725 AC: 1AN: 137962Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 66970
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
137962
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
66970
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 06, 2023 | The c.283G>C (p.E95Q) alteration is located in exon 3 (coding exon 3) of the SYT15 gene. This alteration results from a G to C substitution at nucleotide position 283, causing the glutamic acid (E) at amino acid position 95 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.
LIST_S2
Benign
.;T;.
MetaRNN
Benign
T;T;T
PROVEAN
Benign
N;N;N
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Vest4
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at